Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 2/20 | 0.50 |
| ▸ | LOXL2 | Q9Y4K0 | 2/20 | 0.43 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.37 |
| ▸ | CYP11B1 | P15538 | 3/20 | 0.36 |
| ▸ | CYP11B2 | P19099 | 3/20 | 0.36 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.36 |
| ▸ | MAOA | P21397 | 1/20 | 0.36 |
| ▸ | MAOB | P27338 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | GLA | P06280 | 1/20 | 0.36 |
| ▸ | CCNT1 | O60563 | 2/20 | 0.36 |
| ▸ | CDK9 | P50750 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3375825 | 0.85 | TSHR (0.50) | TSHRNPY5RCCNT1CDK9 | |
| SCHEMBL11744193 | 0.85 | CYP2A6 (0.48) | CYP2A6LOXL2TSHRRAB9AHSD17B10 | |
| SCHEMBL29572432 | 0.85 | CYP2A6 (0.48) | CYP2A6LOXL2TSHRRAB9AHSD17B10 | |
| SCHEMBL9005247 | 0.84 | TSHR (0.43) | TSHRNPY5RCCNT1CDK9 | |
| SCHEMBL9500191 | 0.84 | MLYCD (0.51) | RAB9ACYP11B1CYP11B2ALDH1A1 | |
| SCHEMBL27911911 | 0.83 | TSHR (0.48) | CYP2A6LOXL2TSHRRAB9AHSD17B10 | |
| SCHEMBL10924475 | 0.83 | CYP2A6 (0.47) | CYP2A6LOXL2TSHRRAB9AHSD17B10 | |
| SCHEMBL5718103 | 0.82 | CYP2A6 (0.48) | CYP2A6LOXL2TSHRRAB9AHSD17B10 | |
| SCHEMBL29732415 | 0.81 | GLA (0.60) | MAOBGLACCNT1CDK9 | |
| SCHEMBL1680699 | 0.81 | GLA (0.60) | MAOBGLACCNT1CDK9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 127 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118434796-A | Composition for polyurethane foam, foam prepared therefrom and method thereof | 迈图高新材料公司 | 2024-08-02 | — | — | CN | claimed |
| US-20240400793-A1 | COMPOSITION FOR POLYURETHANE FOAM, FOAM PREPARED THEREFROM AND A METHOD THEREOF | MOMENTIVE PERFORMANCE MATERIALS INC. | 2024-12-05 | — | — | US | disclosed |
| US-12122748-B2 | Optical data communication system comprising para-phenylenevinylenes and specific para-phenylenevinylenes | BASF SE (DE) | 2024-10-22 | — | — | US | disclosed |
| EP-3802490-B1 | OPTICAL DATA COMMUNICATION SYSTEM COMPRISING PARA-PHENYLENEVINYLENES AND SPECIFIC PARA-PHENYLENEVINYLENES | BASF SE (DE) | 2024-09-18 | — | — | EP | disclosed |
| CN-118434796-A | Composition for polyurethane foam, foam prepared therefrom and method thereof | 迈图高新材料公司 | 2024-08-02 | — | — | CN | disclosed |
| CN-112272662-B | Optical data communication system comprising p-phenylenevinylene and specific p-phenylenevinylene | 巴斯夫欧洲公司 | 2024-07-16 | — | — | CN | disclosed |
| EP-4396271-A1 | COMPOSITION FOR POLYURETHANE FOAM, FOAM PREPARED THEREFROM AND A METHOD THEREOF | Momentive Performance Materials Inc. (US) | 2024-07-10 | — | — | EP | disclosed |
| US-20230391727-A1 | ANALOGUES OF PENTAMIDINE AND METHODS FOR TREATING INFECTIONS | AURANSA INC. | 2023-12-07 | — | — | US | disclosed |
| CN-116925032-A | 1, 4-benzodioxane stilbene lignan compound, preparation method thereof and application thereof in resisting tumor | 北京大学 | 2023-10-24 | — | — | CN | disclosed |
| EP-4232014-A1 | ANALOGUES OF PENTAMIDINE AND METHODS FOR TREATING INFECTIONS | Auransa Inc. (US) | 2023-08-30 | — | — | EP | disclosed |
| EP-0144640-A1 | Distyrene compounds | BAYER AG (DE) | 1985-06-19 | — | — | EP | disclosed |
| EP-0137452-A1 | Light-sensitive compounds containing trichloromethyl groups, process for their preparation and light-sensitive mixture containing these compounds | HOECHST AKTIENGESELLSCHAFT (DE) | 1985-04-17 | — | — | EP | disclosed |
| US-4510311-A | Water-insoluble azolystyryl optical brighteners | BAYER AKTIENGESELLSCHAFT (DE) | 1985-04-09 | — | — | US | disclosed |
| US-4464284-A | DICYANO-STYRYL BENZENES | BASF AKTIENGESELLSCHAFT (DE) | 1984-08-07 | — | — | US | disclosed |
| EP-0084667-A2 | Phenylethylene derivatives, their preparation and use as medicines | BASF Aktiengesellschaft (DE) | 1983-08-03 | — | — | EP | disclosed |
| US-4380514-A | FROM TEREPHTHACALDEHYDE AND A PHOSPHONATE COMPOUND | BASF AKTIENGESELLSCHAFT (DE) | 1983-04-19 | — | — | US | disclosed |
| US-4233440-A | OPTICAL BRIGHTENERS | BAYER AKTIENGESELLSCHAFT (DE) | 1980-11-11 | — | — | US | disclosed |
| US-4220760-A | OPTICAL BRIGHTENERS | HOECHST AKTIENGESELLSCHAFT (DE) | 1980-09-02 | — | — | US | disclosed |
| US-4016195-A | OPTICAL BRIGHTENERS | HOECHST AKTIENGESELLSCHAFT (DT) | 1977-04-05 | — | — | US | disclosed |
| US-3957846-A | OPTICAL BRIGHTENERS, LACQUERS, SYNTHETIC FIBERS | HOECHST AKTIENGESELLSCHAFT (DT) | 1976-05-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12122748-B2 | Optical data communication system comprising para-phenylenevinylenes and specific para-phenylenevinylenes | OR10J3, OXER1, CDC73 | CYP2A6 1700/4885LOXL2 1725/4885TSHR 3262/4885 |
| US-20230391727-A1 | ANALOGUES OF PENTAMIDINE AND METHODS FOR TREATING INFECTIONS | ASNS, DPM1, PNP | CYP2A6 4359/4885LOXL2 4134/4885TSHR 3038/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.